SCHEMBL21471580

SCHEMBL21471580

COc1ccccc(-c2ccc(C)cc2)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 1/20 0.47
PTPN1 P18031 1/20 0.47
SYK P43405 1/20 0.46
TNKS2 Q9H2K2 3/20 0.44
TNKS O95271 2/20 0.44
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
USP2 O75604 1/20 0.44
DUSP3 P51452 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4425113 0.84 SYK (0.56) PTPRCPTPN1SYKTNKS2ALDH1A1
SCHEMBL23433177 0.81 HPGD (0.50) PTPRCPTPN1ALDH1A1MEN1KMT2A
SCHEMBL23433235 0.76 ALDH1A1 (0.43) PTPRCPTPN1ALDH1A1MEN1KMT2A
SCHEMBL13241158 0.76 TNKS (0.53) SYKTNKS2TNKSALDH1A1MEN1
SCHEMBL1044693 0.76 NFE2L2 (0.51) SYKTNKS2TNKSALDH1A1MAPT
SCHEMBL11439546 0.75 CA1 (0.67) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL10093046 0.74 ERN1 (0.49) SYKTNKS2TNKSALDH1A1MAPT
SCHEMBL21471599 0.74 HDAC4 (0.49) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL11499533 0.74 SYK (0.53) SYKALDH1A1MEN1KMT2AMAPT
SCHEMBL7932563 0.74 ERN1 (0.44) SYKTNKS2TNKSALDH1A1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163393-A1 HINOKITIOL ANALOGUES, METHODS OF PREPARING AND PHARMACEUTICAL COMPOSITIONS THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2021-06-03 US disclosed
WO-2019200314-A2 HINOKITIOL ANALOGUES, METHODS OF PREPARING AND PHARMACEUTICAL COMPOSITIONS THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163393-A1 HINOKITIOL ANALOGUES, METHODS OF PREPARING AND PHARMACEUTICAL COMPOSITIONS THEREOF CYP27A1, CYP27B1, HSD17B7 PTPRC 3917/4885PTPN1 4666/4885SYK 4020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.